On this page
linkboo is a link-in-bio and link-routing platform with structural support for healthcare-adjacent compliance documentation, audit-log retention, and payment processor flexibility. This page describes how the platform applies to GLP-1 prescribing clinics and telehealth practices (including practices offering semaglutide, tirzepatide, and related agonist therapies for weight management and metabolic indications, in both branded and compounded forms where state-law-permitted).
platform overview
linkboo is a neutral infrastructure tool. The platform handles the link-routing layer between a social-platform profile and a downstream destination URL controlled by the operator (the clinic's website, intake form, scheduling page, or telehealth-platform landing page). The platform does not host patient data, intake records, or transaction layer; it routes the click and records the routing event.
The platform's primary technical feature is structural mitigation of the in-app browser logged-out problem documented across major social platforms. When a click originates inside a social-platform webview, the platform detects the webview from the user-agent string and routes the click out to the device's default browser before the destination loads.
audit logging
The platform retains structured audit logs of routing events. Each routing event records:
- The originating social platform
- The detected browser context
- The destination URL the click was routed to
- The timestamp of the routing event
- The geographic region (country-level)
- The escape-flow technique applied
- The user agent string
The platform does not log personally-identifying information about the visitor. Log retention is configurable per workspace, with a default of 13 months. Logs are exportable in CSV and JSON.
GLP-1 prescribing operators commonly use audit logs to document advertising-channel sources, to support advertising-policy compliance reviews with social platforms (which apply restrictions to weight-loss and prescription-medication advertising), and to maintain marketing-trail records compatible with state medical-board advertising-disclosure requirements and applicable FDA / FTC marketing rules.
payment processor and intake-platform flexibility
The platform does not process payments and does not have a dependency on any specific intake or practice-management platform. The destination URL routed to is configurable by the operator and can be changed at any time. GLP-1 prescribing operators commonly route to Healthie, Spruce, Cerbo, or proprietary intake destinations; transitioning between intake platforms, between state-cohort intake flows (different state regulations routing to different intake forms), or between branded-product and compounded-product fulfillment destinations is a destination-URL configuration change at the platform level.
attribution
The platform records click-source attribution per routing event. The operator's dashboard surfaces:
- Click volume per source platform
- Click volume per destination URL
- Click volume per link
- Detected-webview-share per source platform
The attribution layer is independent of the operator's destination-side analytics. The platform does not set or share cookies with the destination.
acceptable use
This page is intended for operators whose clinical practice and advertising comply with applicable law. Relevant categories include: state medical-board regulations governing prescribing practice scope, telehealth-practice-act compliance for cross-state prescribing, the FDA's restrictions on prescription-medication advertising (DTC restrictions and applicable marketing-claim rules), FTC marketing-claim restrictions on weight-loss outcomes, and state-specific pharmacy-board rules where compounded products are prescribed. The platform's acceptable use policy is the document of record for category-eligibility, content restrictions, and routing-destination restrictions.
The platform applies the acceptable use policy uniformly across all signups.
signup
Signup is direct, no sales call, no underwriting interview at the platform level. The operator is responsible for ensuring their downstream destination, clinical practice, and advertising comply with applicable law and with each social platform's terms.
Direct any policy questions to the acceptable use policy.